Cited by 88Genetics and Neurodevelopmental DisordersNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity

Open access
Jin, Lee-Way, Horiuchi, Makoto, Wulff, Heike, Liu, Xiao-Bo, Cortopassi, Gino A., Erickson, Jeffrey D., Maezawa, Izumi·2015·The Journal of Neuroscience

Abstract

Rett syndrome (RTT) is an autism spectrum disorder caused by loss-of-function mutations in the gene encoding MeCP2, an epigenetic modulator that binds the methyl CpG dinucleotide in target genes to regulate transcription. Previously, we and others reported a role of microglia in the pathophysiology of RTT. To understand the mechanism of microglia dysfunction in RTT, we identified a MeCP2 target gene, SLC38A1, which encodes a major glutamine transporter (SNAT1), and characterized its role in microglia. We found that MeCP2 acts as a microglia-specific transcriptional repressor of SNAT1. Because glutamine is mainly metabolized in the mitochondria, where it is used as an energy substrate and a precursor for glutamate production, we hypothesize that SNAT1 overexpression in MeCP2-deficient microglia would impair the glutamine homeostasis, resulting in mitochondrial dysfunction as well as microglial neurotoxicity because of glutamate overproduction. Supporting this hypothesis, we found that MeCP2 downregulation or SNAT1 overexpression in microglia resulted in (1) glutamine-dependent decrease in microglial viability, which was corroborated by reduced microglia counts in the brains of MECP2 knock-out mice; (2) proliferation of mitochondria and enhanced mitochondrial production of reactive oxygen species; (3) increased oxygen consumption but decreased ATP production (an energy-wasting state); and (4) overproduction of glutamate that caused NMDA receptor-dependent neurotoxicity. The abnormalities could be rectified by mitochondria-targeted expression of catalase and a mitochondria-targeted peptide antioxidant, Szeto-Schiller 31. Our results reveal a novel mechanism via which MeCP2 regulates bioenergetic pathways in microglia and suggest a therapeutic potential of mitochondria-targeted antioxidants for RTT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2778-14.2015

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I.
Affiliations
  • University of California Davis Medical Center (US)
  • University of California, Davis (US)
  • Louisiana State University (US)
Venue
The Journal of Neuroscience
Published
2015-02-11
Volume
35
Issue
6
Pages
2516-2529
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2092719082
Cited by
88
References
71
Citations by year
2026: 3 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 7 · 2015: 3
FWCI
8.02
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (GM076063)
  • National Institute of General Medical Sciences (GM076063, R01GM076063)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD079125, HD073631, R01HD064817, R21HD073631, HD064817)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Rett syndrome, MeCP2, SNAT1, SLC38A1, glutamine transporter, microglia, mitochondrial dysfunction, reactive oxygen species, catalase, mitochondria-targeted antioxidants, transcriptional repression, Mecp2 knockout mice
MeSH terms
Adenosine Triphosphate, Animals, Glycine, Mice, Inbred C57BL, Oxygen Consumption, Rett Syndrome, Microglia, Mice, Knockout, Glutamic Acid, Neurotoxicity Syndromes, Amino Acid Transport System A, Mitochondrial Diseases, Mice, Methyl-CpG-Binding Protein 2, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review